卖什么
We provide a curated, evidence- based answer to any clinical question.
商业模式拆解
买家：谁掌握预算？
Pharmacy directors / health system leaders who hire a virtual DI pharmacist service (30+ health systems); individual clinical pharmacists can sign up free.
触发点：什么让他们现在购买？
Drug information literature searching is tedious and consumes pharmacist FTEs; health systems want pharmacists to practice at top of license.
工作流：什么输入变成什么输出？
A pharmacist submits a clinical question; InpharmD researchers plus AI perform a custom literature search and return a customized evidence-based answer within the requested time; prior answers searchable.
经济账：省了什么，怎么收费？
Health-system subscription for a virtual drug information service; claims 4x+ ROI, 163,258 pharmacist hours saved, and a study showing $5.2M saved and 45 fewer deaths.
渠道：怎么接触到客户？
Free sign-up for 20,000+ individual pharmacists funnels to health-system contracts; case studies (UCLA Health, OhioHealth, Riverside).
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2021 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.